Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis - Institut Pasteur Access content directly
Journal Articles Comparative Immunology, Microbiology and Infectious Diseases Year : 2010

Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis

Abstract

Pseudotuberculosis, an infection caused by the ubiquitous enteropathogenic bacterium Yersinia pseudotuberculosis, is a recurrent veterinary problem in livestock and zoo animals. The only vaccine currently available in zoos is Pseudovac (a mixture of killed strains of various serotypes), but its efficacy is not well established. We show here that Pseudovac does not protect guinea pigs against a severe Y. pseudotuberculosis infection. We thus evaluated the possibility of using a live attenuated Y. pseudotuberculosis strain (IP32680) as an oral vaccine against animal pseudotuberculosis. We report that IP32680 is avirulent for guinea pigs and induces a strong IgG response against various serotypes of Y. pseudotuberculosis. One and two oral inoculations of IP32680 provided 50% and 83% protection, respectively against a severe infection with a highly pathogenic strain. The avirulent Y. pseudotuberculosis IP32680 is therefore much more protective than Pseudovac and may represent a valuable oral vaccine against pseudotuberculosis in zoo animals.
Fichier principal
Vignette du fichier
Quintard preprint 2010.pdf (433.5 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

pasteur-02075702 , version 1 (21-03-2019)

Identifiers

Cite

Benoît Quintard, Thierry Petit, Nathalie Ruvoen, Elisabeth Carniel, Christian E. Demeure. Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis. Comparative Immunology, Microbiology and Infectious Diseases, 2010, 33 (6), pp.e59-e65. ⟨10.1016/j.cimid.2009.12.001⟩. ⟨pasteur-02075702⟩
79 View
416 Download

Altmetric

Share

Gmail Facebook X LinkedIn More